These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 12608553)

  • 21. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy.
    Warnar C; Faber E; Katinakis PA; Schermer T; Spronk PE
    J Clin Monit Comput; 2022 Jun; 36(3):871-877. PubMed ID: 33991270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N; Baldwin I; Johnstone M; Egi M; Bellomo R
    Int J Artif Organs; 2007 Apr; 30(4):301-7. PubMed ID: 17520566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF).
    Hofmann RM; Maloney C; Ward DM; Becker BN
    Ren Fail; 2002 May; 24(3):325-35. PubMed ID: 12166699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S; Scholle C; Voss G; Haase M; Vargas-Hein O; Krausch D; Melzer C; Rosseau S; Zuckermann-Becker H; Neumayer HH
    Nephron Clin Pract; 2004; 97(4):c131-6. PubMed ID: 15331942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous veno-venous hemofiltration with regional citrate anticoagulation: a four-year single-center experience.
    Cassina T; Mauri R; Engeler A; Giannini O
    Int J Artif Organs; 2008 Nov; 31(11):937-43. PubMed ID: 19089795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting.
    Naka T; Egi M; Bellomo R; Cole L; French C; Botha J; Wan L; Fealy N; Baldwin I
    Anaesth Intensive Care; 2005 Oct; 33(5):601-8. PubMed ID: 16235478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of acid-base control, electrolyte balance, and filter patency of a Prismaflex-based regional citrate anticoagulation protocol for pre-dilution continuous veno-venous hemodiafiltration.
    Khadzhynov D; Slowinski T; Lieker I; Neumayer HH; Peters H
    Clin Nephrol; 2014 May; 81(5):320-30. PubMed ID: 24780554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate anticoagulation during CVVH in high risk bleeding patients.
    Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A
    Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.